Pharmaceutical

Generate:Biomedicines secures $273m to advance therapeutic portfolio 

Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.

Sep 15, 2023 - 20:00
Generate:Biomedicines secures $273m to advance therapeutic portfolio 
Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.
Read the original article

Tags:

Previous Article

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Next Article

No more cookies: How healthcare companies can gain trust for data consent

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Lilly reaches $2.4 million settlement with EEOC over age discrimination lawsuit

STAT+: Lilly reaches $2.4 million settlement with EEOC ...

Jun 28, 2023

Eisai lowers Leqembi revenue forecast after rocky entry to market

Eisai lowers Leqembi revenue forecast after rocky entry...

Nov 9, 2024

Twist Bioscience and Bayer partner for antibody discovery

Twist Bioscience and Bayer partner for antibody discovery

Oct 7, 2023